Predictors of functional benefit of hepatitis C therapy in a ‘real-life’ cohort

AIM: To define predictors of functional benefit of direct-acting antivirals (DAAs) in patients with chronic hepatitis C virus (HCV) infection and liver cirrhosis. METHODS: We analysed a cohort of 199 patients with chronic HCV genotype 1, 2, 3 and 4 infection involving previously treated and untreate...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinebrunner, Niels, Stein, Kerstin, Sandig, Catharina, Bruckner, Thomas, Stremmel, Wolfgang, Pathil, Anita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807943/
https://www.ncbi.nlm.nih.gov/pubmed/29467555
http://dx.doi.org/10.3748/wjg.v24.i7.852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807943/
https://www.ncbi.nlm.nih.gov/pubmed/29467555
http://dx.doi.org/10.3748/wjg.v24.i7.852

Ejemplares similares